Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | VIV | CMCSA |
|---|---|---|
| Price | $11.33 | $21.63 |
| Change today | ▼ 1.09% | ▼ 0.62% |
| Market cap | $18.10B | $76.74B |
| Return, 3 months | -11.6% | -8.9% |
| Return, year to date | +1.6% | -19.9% |
| Return, 1 year | -3.8% | -22.6% |
| P/E (TTM) | 14.2 | 6.9 |
| P/B | 1.4 | 0.9 |
| P/E percentile vs own 5y | – | 20th |
| Dividend yield | 8.49% | 6.10% |
| Revenue growth (YoY, latest qtr) | – | -1.2% |
| Net profit growth (YoY) | – | -69.0% |
| Gross margin | – | 69.4% |
| Operating margin | – | 14.7% |
| Net margin | – | 9.0% |
| Return on equity | – | 12.0% |
| Analyst target vs. price | +32.5% | +28.0% |
| Analyst buy share | 0% | 33% |
| RSI (14) | 42 | 31 |
| 30-day volatility | 20.2% | 32.0% |
| Max drawdown, 1 year | -31.2% | -31.8% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Sell | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
